How to Value a Naturopathic Clinic in 2026

Naturopathic clinics get valued higher than most people expect. While a solo acupuncturist might sell for 1.5-2.0x SDE, a well-run ND practice with a strong supplement dispensary and IV therapy program routinely trades at 2.5-4.0x SDE. The reason is simple: naturopathic clinics generate three distinct revenue streams, and two of them are genuinely recurring.

Here's how these practices actually get priced in 2026, and what you need to do to be on the high end of that range.

The Three Revenue Streams

Naturopathic clinics combine three business models, and buyers value each differently:

Clinical visits — the core business, typically $150-400 per visit for new patient intakes and $90-220 for follow-ups. Most ND clinics are cash-pay with superbills provided for patient self-submission, though some states (Washington, Oregon, Arizona, Vermont) have broader insurance coverage. This revenue stream behaves like any other practitioner-dependent professional service.

Supplement and dispensary sales — professional-grade products from suppliers like Thorne, Pure Encapsulations, Metagenics, Designs for Health, and Standard Process. Gross margin runs 35-45% after practitioner commissions, and a significant portion of sales come through Fullscript or Wellevate auto-ship subscriptions that generate genuine recurring revenue. In a mature ND practice, supplement revenue often runs 25-40% of total revenue.

IV therapy and injectables— Myers' cocktails, high-dose vitamin C, glutathione pushes, B12 shots, NAD+ infusions. IV services bill $125-400 per session at 55-70% gross margin. This is the fastest-growing revenue stream in the industry and the one buyers get most excited about.

The Multiples

ND clinics sell on SDEwhen they're under $1.5M in revenue and shift toward EBITDA-based pricing for larger multi-practitioner clinics. Here's the range:

• 2.0-2.5x SDE: Solo ND, clinical visits only, minimal supplement revenue, no IV program, owner-dependent.
• 2.5-3.0x SDE: 2+ practitioners, functioning supplement dispensary at 20%+ of revenue, starting or small IV program, 3+ years in business.
• 3.0-3.5x SDE: Multi-practitioner clinic, supplement revenue 30%+, established IV/injection program, retained associates, strong online presence and reviews.
• 3.5-4.0x SDE: Premium clinics with high-volume IV lounges, $200K+ annual supplement subscriptions via Fullscript, multiple NDs, documented protocols, and meaningful growth.

A clinic doing $900K in revenue with $240K SDE typically sells between $480K and $960K. The spread is enormous because the three revenue streams scale differently and buyers pay premiums for the recurring ones.

Why Supplement Revenue Is Worth More Than Clinical Revenue

Clinical visits are practitioner-dependent. When you leave, many patients leave with you. Supplement subscriptions through Fullscript or Wellevate, by contrast, live in the patient's account and auto-refill regardless of who's in the exam room that week. They're closer to subscription software economics than healthcare economics.

Buyers understand this. A clinic doing $700K total with $200K from Fullscript auto-ships is substantially more valuable than a clinic doing $700K total with $50K from walk-in supplement sales. The auto-ship revenue survives a practitioner change. Walk-in sales don't.

Before going to market, pull a report from Fullscript showing your active subscriber count, average order value, churn rate, and monthly recurring revenue. That one report can be worth $100K+ at closing if the numbers are strong. Buyers will also ask for a payout report showing gross revenue to the practice, not just the commission.

IV Therapy: The Growth Multiplier

IV therapy has transformed ND clinic economics over the past five years. Practices with dedicated IV lounges — comfortable chairs, multiple stations, IV-trained staff — can generate $200K-$600K annually from IV alone at 60%+ gross margin.

Buyers pay premiums for IV programs because they're less practitioner-dependent than clinical visits. Protocols are documented, RN or certified IV staff can administer treatments, and many patients come on a standing schedule (weekly or biweekly) regardless of which ND they originally consulted. It's the closest thing to a recurring service revenue stream in this industry.

That said, IV therapy carries regulatory risk. Scope of practice varies by state, compounding rules apply to anything prepared on-site, and several states have tightened oversight of standalone IV clinics. Buyers will want to see state board guidance, supplier agreements with 503B compounders where applicable, and clear delegation and standing order protocols.

Who Buys ND Clinics

The buyer pool for naturopathic clinics is more interesting than for most wellness businesses because institutional interest is real and growing. Realistic buyers include:

• Other naturopathic doctors — the most common buyer for clinics under $1M in revenue, usually SBA 7(a) financed.
• Functional medicine practices (MD and DO) adding ND services to their offering.
• Integrative medicine groups rolling up multi-modality clinics.
• IV therapy chains and wellness operators looking to acquire established IV programs with existing patient bases.
• Small PE-backed roll-ups in integrative health — still early, but the activity is real for clinics with $500K+ in EBITDA.

If your clinic is large enough to attract institutional interest, expect them to value on EBITDA at 5-7x with an earnout structure. That can produce higher total consideration than an SDE-based owner-operator sale, but it also means you're staying on for 3-5 years.

What Destroys ND Clinic Value

Supplement sales through Amazon or personal websites. Some NDs sell supplements through personal Amazon stores or their own e-commerce site rather than Fullscript. That revenue is often harder to transfer to a buyer because the accounts are personal, not clinic-owned. Get everything on a clinic-branded dispensary platform before you sell.

Cash supplement sales off the books. This kills value the same way off-book herbal sales do in TCM practices. If it's not on the P&L, it can't be sold.

Owner-compounded IV bags. Mixing your own IV cocktails from bulk ingredients without proper 503A compounding compliance is both a regulatory risk and a value killer. Buyers will refuse to take on the exposure. Move to premade bags from 503B compounders or properly registered compounding pharmacies.

No EHR and no patient database. ND clinics that run on paper charts or basic Google Docs can't produce the patient retention and LTV data buyers need. Get on Practice Better, Cerbo, or similar well before sale.

Preparing Your ND Clinic for Sale

The 18-24 month playbook is clear. Grow your Fullscript subscriber base aggressively — every new auto-ship subscriber adds directly to enterprise value. Build or expand your IV program if you haven't already, with proper protocols and staff. Bring on an associate ND to reduce owner dependency. Get your regulatory house in order, especially around IV compounding and any injectables. Clean your books and separate personal expenses from clinic expenses so your SDE calculation survives diligence.

Then document everything: patient intake protocols, treatment plans, supplement recommendation workflows, IV protocols, and marketing funnels. A buyer who sees a systematized clinic pays 20-30% more than one who sees a solo practitioner with good instincts.

The Bottom Line

Naturopathic clinics are one of the best-positioned small healthcare businesses to sell in 2026. Multiples are strong because the business model generates real recurring revenue through supplement subscriptions and IV memberships, and institutional interest is growing. But realizing those multiples requires building the clinic as a business rather than a practice. Do that and 3-4x SDE is genuinely achievable. Skip it and you're back to 2x like every other owner-dependent cash-pay clinic.